We are live on ! Find out more
DARE icon

Dare Bioscience
DARE

36 hedge funds and large institutions have $9.12M invested in Dare Bioscience in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 17 increasing their positions, 5 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

240% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 5

0.01% more ownership

Funds ownership: 0.72% → 0.73% (+0.01%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

8% less capital invested

Capital invested by funds: $9.89M → $9.12M (-$768K)

10% less funds holding

Funds holding: 40 → 36 (-4)

44% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 9

Holders
36
Holders Change
-4
Holders Change %
-10%
% of All Funds
0.61%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
17
Reduced
5
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$334K
2
SAM
Soviero Asset Management
New York
+$251K
3
Millennium Management
Millennium Management
New York
+$237K
4
BlackRock
BlackRock
New York
+$140K
5
FFS
Founders Financial Securities
Maryland
+$130K

Top Sellers

Rank Fund Capital Flow
1
GCP
GSA Capital Partners
United Kingdom
-$117K
2
Marshall Wace
Marshall Wace
United Kingdom
-$110K
3
ECM
ExodusPoint Capital Management
New York
-$108K
4
Jane Street
Jane Street
New York
-$87K
5
Citadel Advisors
Citadel Advisors
Florida
-$63K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$4.31M +$63K +4,187 +1%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$880K +$21.3K +1,417 +2%
BlackRock
3
BlackRock
New York
$878K +$140K +9,329 +19%
SAM
4
Soviero Asset Management
New York
$615K +$251K +16,667 +67%
Millennium Management
5
Millennium Management
New York
$547K +$237K +15,758 +74%
Renaissance Technologies
6
Renaissance Technologies
New York
$451K +$334K +22,188 +265%
State Street
7
State Street
Massachusetts
$274K +$54.8K +3,642 +24%
Northern Trust
8
Northern Trust
Illinois
$199K +$26K +1,728 +15%
FFS
9
Founders Financial Securities
Maryland
$127K +$130K +8,625 New
FFA
10
Founders Financial Alliance
North Carolina
$126K +$129K +8,542 New
IVM
11
InterWest Venture Management
California
$76K – – –
HighTower Advisors
12
HighTower Advisors
Illinois
$76K +$40.1K +2,667 +107%
T. Rowe Price Associates
13
T. Rowe Price Associates
Maryland
$72K – – –
VF
14
Virtu Financial
New York
$65K +$66.2K +4,402 New
Commonwealth Equity Services
15
Commonwealth Equity Services
Massachusetts
$53K +$20K +1,330 +58%
GCP
16
GSA Capital Partners
United Kingdom
$40K -$117K -7,800 -74%
Charles Schwab
17
Charles Schwab
California
$38K – – –
RJFSA
18
Raymond James Financial Services Advisors
Florida
$37K – – –
CIBC Private Wealth Group
19
CIBC Private Wealth Group
Georgia
$31K – – –
Bank of New York Mellon
20
Bank of New York Mellon
New York
$31K +$3.48K +231 +12%
TRCT
21
Tower Research Capital (TRC)
New York
$30K -$21.7K -1,443 -41%
Osaic Holdings
22
Osaic Holdings
Arizona
$27K +$1.81K +120 +7%
XT
23
XTX Topco
Cayman Islands
$23K -$8.76K -582 -27%
ASN
24
Advisory Services Network
Georgia
$21K +$2.51K +167 +13%
CSS
25
Cubist Systematic Strategies
Connecticut
$21K +$21.1K +1,403 New
1
2

DARE Hedge Fund Activity: Q2 2022 in Review

36 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q2 2022, worth a combined $9.12M — down 7.8% from $9.89M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of DARE and 5 opened new positions — a net loss of 4 holders — while 5 trimmed existing stakes and 17 added.

The largest buyer was Renaissance Technologies, adding an estimated $334K. The largest seller was GSA Capital Partners, cutting an estimated $117K.

  • 36 institutional investors held Dare Bioscience (DARE) as of Q2 2022, down from 40 in Q1 2022.
  • Funds reported $9.12M of Dare Bioscience stock for Q2 2022, down 7.8% quarter-over-quarter.
  • 5 funds opened new Dare Bioscience positions in Q2 2022 and 9 closed out, a net change of -4 holders.
  • The largest Dare Bioscience buyer in Q2 2022 was Renaissance Technologies, an estimated $334K added.
  • The largest Dare Bioscience seller in Q2 2022 was GSA Capital Partners, an estimated $117K sold.

Based on aggregated 13F filings for Q2 2022.